Repligen
RGEN
434 hedge funds and large institutions have $9.56B invested in Repligen in 2022 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 136 increasing their positions, 159 reducing their positions, and 38 closing their positions.
89% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 38
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
17% more capital invested
Capital invested by funds: $8.17B → $9.56B (+$1.39B)
7% more funds holding
Funds holding: 405 → 434 (+29)
1.2% more ownership
Funds ownership: 90.77% → 91.97% (+1.2%)
14% less repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 159
34% less call options, than puts
Call options by funds: $45.4M | Put options by funds: $69.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sands Capital Management
Arlington,
Virginia
|
+$346M |
| 2 |
BlackRock
New York
|
+$119M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$109M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$100M |
| 5 |
PG
Pendal Group
Sydney,
Australia
|
+$94.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$395M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$73.6M |
| 3 |
Renaissance Technologies
New York
|
-$49.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$41.2M |
| 5 |
ESCM
Echo Street Capital Management
New York
|
-$39.3M |
RGEN Hedge Fund Activity: Q3 2022 in Review
434 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q3 2022, worth a combined $9.56B — up 17% from $8.17B a quarter earlier.
Buyers outnumbered sellers: 72 funds opened new RGEN positions and 38 closed out — a net gain of 34 holders — while 136 added to existing stakes and 159 trimmed.
The largest buyer was Sands Capital Management, opening a new position worth an estimated $346M. The largest seller was T. Rowe Price Associates, cutting an estimated $395M.
- 434 institutional investors held Repligen (RGEN) as of Q3 2022, up from 405 in Q2 2022.
- Funds reported $9.56B of Repligen stock for Q3 2022, up 17% quarter-over-quarter.
- 72 funds opened new Repligen positions in Q3 2022 and 38 closed out, a net change of +34 holders.
- The largest Repligen buyer in Q3 2022 was Sands Capital Management, an estimated $346M added.
- The largest Repligen seller in Q3 2022 was T. Rowe Price Associates, an estimated $395M sold.
Based on aggregated 13F filings for Q3 2022.